BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 16410818)

  • 1. Proton beam therapy for iris melanoma: a review of 15 cases.
    Rundle P; Singh AD; Rennie I
    Eye (Lond); 2007 Jan; 21(1):79-82. PubMed ID: 16410818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton beam therapy for iris melanomas.
    Lumbroso-Le Rouic L; Delacroix S; Dendale R; Levy-Gabriel C; Feuvret L; Noel G; Plancher C; Nauraye C; Garcia P; Calugaru V; Asselain B; Desjardins L
    Eye (Lond); 2006 Nov; 20(11):1300-5. PubMed ID: 16294207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton beam radiotherapy of iris melanoma.
    Damato B; Kacperek A; Chopra M; Sheen MA; Campbell IR; Errington RD
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):109-15. PubMed ID: 16111578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton beam radiotherapy of diffuse iris melanoma in 54 patients.
    Willerding GD; Cordini D; Hackl C; Karle B; Lakotka N; Foerster MH; Bechrakis NN; Heufelder J; Moser L; Joussen AM
    Br J Ophthalmol; 2015 Jun; 99(6):812-6. PubMed ID: 25505288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton beam therapy and iris neovascularisation in uveal melanoma.
    Boyd SR; Gittos A; Richter M; Hungerford JL; Errington RD; Cree IA
    Eye (Lond); 2006 Jul; 20(7):832-6. PubMed ID: 16167079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plaque radiotherapy for residual or recurrent iris melanoma after surgical resection in 32 cases.
    Shah SU; Shields CL; Bianciotto C; Emrich J; Komarnicky L; Shields JA
    Ophthalmology; 2012 Apr; 119(4):838-842.e2. PubMed ID: 22133794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ruthenium plaque radiation therapy for iris and iridociliary melanomas.
    Razzaq L; Keunen JE; Schalij-Delfos NE; Creutzberg CL; Ketelaars M; de Keizer RJ
    Acta Ophthalmol; 2012 May; 90(3):291-6. PubMed ID: 20670343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton therapy of uveal melanomas in Berlin. 5 years of experience at the Hahn-Meitner Institute.
    Höcht S; Bechrakis NE; Nausner M; Kreusel KM; Kluge H; Heese J; Heufelder J; Cordini D; Homeyer H; Fuchs H; Martus P; Foerster MH; Wiegel T; Hinkelbein W
    Strahlenther Onkol; 2004 Jul; 180(7):419-24. PubMed ID: 15241529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of iris melanoma after proton beam therapy.
    Sandinha MT; Kacperek A; Errington RD; Coupland SE; Damato B
    Br J Ophthalmol; 2014 Apr; 98(4):484-7. PubMed ID: 24414401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton therapy of iris melanoma with 50 CGE : Influence of target volume on clinical outcome.
    Riechardt AI; Karle B; Cordini D; Heufelder J; Budach V; Joussen AM; Gollrad J
    Strahlenther Onkol; 2017 Nov; 193(11):943-950. PubMed ID: 28631017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular complications after iodine brachytherapy for large uveal melanomas.
    Puusaari I; Heikkonen J; Kivelä T
    Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes.
    Shields CL; Shah SU; Bianciotto CG; Emrich J; Komarnicky L; Shields JA
    Ophthalmology; 2013 Jan; 120(1):55-61. PubMed ID: 22980742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole anterior segment proton beam radiotherapy for diffuse iris melanoma.
    Konstantinidis L; Roberts D; Errington RD; Kacperek A; Damato B
    Br J Ophthalmol; 2013 Apr; 97(4):471-4. PubMed ID: 23298884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma of the iris: report of 72 cases treated surgically.
    Arentsen JJ; Green WR
    Ophthalmic Surg; 1975; 6(2):23-37. PubMed ID: 1153157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications.
    Shields CL; Naseripour M; Shields JA; Freire J; Cater J
    Am J Ophthalmol; 2003 May; 135(5):648-56. PubMed ID: 12719072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of metastatic tumors of the choroid with proton beam irradiation.
    Tsina EK; Lane AM; Zacks DN; Munzenrider JE; Collier JM; Gragoudas ES
    Ophthalmology; 2005 Feb; 112(2):337-43. PubMed ID: 15691572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton beam therapy for presumed and confirmed iris melanomas: a review of 36 cases.
    Rahmi A; Mammar H; Thariat J; Angellier G; Herault J; Chauvel P; Kodjikian L; Denis P; Grange JD
    Graefes Arch Clin Exp Ophthalmol; 2014 Sep; 252(9):1515-21. PubMed ID: 25038910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma.
    Marucci L; Lane AM; Li W; Egan KM; Gragoudas ES; Adams JA; Collier JM; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1018-22. PubMed ID: 16376492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of radiation maculopathy after palladium-103 plaque radiotherapy for iris melanoma.
    Yousef YA; Finger PT
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1107-12. PubMed ID: 22172910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage proton beam therapy for recurrent iris melanoma: outcome and side effects.
    Riechardt AI; Klein JP; Cordini D; Heufelder J; Rehak M; Seibel I; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2018 Jul; 256(7):1325-1332. PubMed ID: 29464331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.